188 related articles for article (PubMed ID: 15345185)
1. Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity.
Rogliani P; Amicosante M; Berretta F; Dotti C; Bocchino M; O'Donnell KM; Saltini C
Int J Immunopathol Pharmacol; 2004; 17(2 Suppl):3-10. PubMed ID: 15345185
[TBL] [Abstract][Full Text] [Related]
2. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells.
Amicosante M; Berretta F; Franchi A; Rogliani P; Dotti C; Losi M; Dweik R; Saltini C
Eur Respir J; 2002 Nov; 20(5):1174-8. PubMed ID: 12449171
[TBL] [Abstract][Full Text] [Related]
3. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.
Bill JR; Mack DG; Falta MT; Maier LA; Sullivan AK; Joslin FG; Martin AK; Freed BM; Kotzin BL; Fontenot AP
J Immunol; 2005 Nov; 175(10):7029-37. PubMed ID: 16272364
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility locus genetic markers of beryllium sensitization and disease.
Saltini C; Richeldi L; Losi M; Amicosante M; Voorter C; van den Berg-Loonen E; Dweik RA; Wiedemann HP; Deubner DC; Tinelli C
Eur Respir J; 2001 Oct; 18(4):677-84. PubMed ID: 11716174
[TBL] [Abstract][Full Text] [Related]
5. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.
Lombardi G; Germain C; Uren J; Fiorillo MT; du Bois RM; Jones-Williams W; Saltini C; Sorrentino R; Lechler R
J Immunol; 2001 Mar; 166(5):3549-55. PubMed ID: 11207315
[TBL] [Abstract][Full Text] [Related]
6. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS
Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942
[TBL] [Abstract][Full Text] [Related]
7. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.
Fontenot AP; Torres M; Marshall WH; Newman LS; Kotzin BL
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12717-22. PubMed ID: 11050177
[TBL] [Abstract][Full Text] [Related]
8. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.
Maier LA; McGrath DS; Sato H; Lympany P; Welsh K; Du Bois R; Silveira L; Fontenot AP; Sawyer RT; Wilcox E; Newman LS
J Immunol; 2003 Dec; 171(12):6910-8. PubMed ID: 14662898
[TBL] [Abstract][Full Text] [Related]
9. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease.
Maier L; Martyny J; Mroz M; McGrath D; Lympany P; duBois R; Zhang L; Murphy J; Newman LS
Chest; 2002 Mar; 121(3 Suppl):81S. PubMed ID: 11893702
[No Abstract] [Full Text] [Related]
10. Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69.
Amicosante M; Sanarico N; Berretta F; Arroyo J; Lombardi G; Lechler R; Colizzi V; Saltini C
Hum Immunol; 2001 Jul; 62(7):686-93. PubMed ID: 11423174
[TBL] [Abstract][Full Text] [Related]
11. TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization.
McCanlies EC; Schuler CR; Kreiss K; Frye BL; Ensey JS; Weston A
J Occup Environ Med; 2007 Apr; 49(4):446-52. PubMed ID: 17426528
[TBL] [Abstract][Full Text] [Related]
12. Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.
Gaede KI; Amicosante M; Schürmann M; Fireman E; Saltini C; Müller-Quernheim J
J Mol Med (Berl); 2005 May; 83(5):397-405. PubMed ID: 15750822
[TBL] [Abstract][Full Text] [Related]
13. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.
Wang Z; White PS; Petrovic M; Tatum OL; Newman LS; Maier LA; Marrone BL
J Immunol; 1999 Aug; 163(3):1647-53. PubMed ID: 10415070
[TBL] [Abstract][Full Text] [Related]
14. Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69.
Amicosante M; Berretta F; Rossman M; Butler RH; Rogliani P; van den Berg-Loonen E; Saltini C
Respir Res; 2005 Aug; 6(1):94. PubMed ID: 16098233
[TBL] [Abstract][Full Text] [Related]
15. Linking genetic susceptibility and T cell activation in beryllium-induced disease.
Falta MT; Bowerman NA; Dai S; Kappler JW; Fontenot AP
Proc Am Thorac Soc; 2010 May; 7(2):126-9. PubMed ID: 20427584
[TBL] [Abstract][Full Text] [Related]
16. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization.
Sato H; Silveira L; Fingerlin T; Dockstader K; Gillespie M; Lagan AL; Lympany P; Sawyer RT; du Bois RM; Welsh KI; Maier LA
J Allergy Clin Immunol; 2007 Mar; 119(3):687-96. PubMed ID: 17208287
[TBL] [Abstract][Full Text] [Related]
17. T cell recognition in chronic beryllium disease.
Amicosante M; Fontenot AP
Clin Immunol; 2006 Nov; 121(2):134-43. PubMed ID: 16697706
[TBL] [Abstract][Full Text] [Related]
18. Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test.
Amicosante M; Deubner D; Saltini C
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):175-9. PubMed ID: 16315779
[TBL] [Abstract][Full Text] [Related]
19. HLA-DPB1 and chronic beryllium disease: a HuGE review.
McCanlies EC; Kreiss K; Andrew M; Weston A
Am J Epidemiol; 2003 Mar; 157(5):388-98. PubMed ID: 12615603
[TBL] [Abstract][Full Text] [Related]
20. Beryllium disease.
Saltini C; Amicosante M
Am J Med Sci; 2001 Jan; 321(1):89-98. PubMed ID: 11202485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
